RemedyRepack Inc. recalls Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx on
Recalled April 12, 2023 · FDA recall D-0492-2023 · RemedyRepack
Hazard
cGMP Deviations · FDA Class II
Units
a) 58 bottles, b) 6 bottles
Sold at
RemedyRepack distributed product to consignees nationwide within the United States
Description
cGMP Deviations
Product
Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.
Manufacturer(s)
RemedyRepack Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →